| # | Drug | Count |
|---|---|---|
| 0 | AFLIBERCEPT | 8 |
| 1 | RANIBIZUMAB | 7 |
| 2 | SIMVASTATIN | 6 |
| 3 | ASPIRIN | 5 |
| 4 | ASPIRIN 325 MG | 5 |
| 5 | ASPIRIN 81 MG | 5 |
| 6 | ATORVASTATIN CALCIUM | 5 |
| 7 | METFORMIN | 5 |
| 8 | IBUPFROFEN | 4 |
| 9 | IBUPROFEN | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLEVIDIPINE | 1 | 0.0027 |
| 1 | LOTEPREDNOL ETABONATE AND TOBRAMYCIN | 1 | 0.0025 |
| 2 | PROPARACAINE HYDROCHLORIDE | 1 | 0.0019 |
| 3 | TRIMIPRAMINE | 2 | 0.0018 |
| 4 | PEGCETACOPLAN | 2 | 0.0011 |
| 5 | SULINDAC | 2 | 0.0008 |
| 6 | VANDETANIB | 1 | 0.0006 |
| 7 | ROPIVACAINE HYDROCHLORIDE | 1 | 0.0004 |
| 8 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0004 |
| 9 | ARTIFICIAL TEARS | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 2 | Antiseptic [EPC] | 1 | 0.0002 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 16 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 5 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 6 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Estrogen Receptor Antagonist [EPC] | 2 | 0.0000 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 9 | Folate Analog [EPC] | 2 | 0.0000 |